Across TCGA pan-cancer cohorts, RPL4P7 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL4P7’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL4P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL4P7 is over-expressed in tumor, although a few such as BLCA and THCA show the opposite, repressed pattern.

COAD, HNSC, and KIRC are the cancer types where RPL4P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL4P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.063	.003	4	view →
HNSC	Female	All	+0.042	.016	4	view →
KIRC	Male	All	+0.017	.021	4	view →
BLCA	All	All	−0.043	.033	3	view →
THCA	Male	II,III,IV	−0.054	.019	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPL4P7 RNA expression & survival · all RPL4P7 data types